Echocardiographic characteristics of PRKAG2 syndrome: a research using three-dimensional speckle tracking echocardiography compared with sarcomeric hypertrophic cardiomyopathy

Table 3 3D STE parameters

Variable	PRKAG2	Healthy	HCM	P1	P2
EDV, ml	107.89 ± 34.79	81.16 ± 21.80	89.58 ± 32.80	0.002	0.183
ESV, ml	46.06 ± 25.80	29.72 ± 12.28	44.61 ± 21.57	0.001	0.874
SV, ml	61.83 ± 13.52	51.43 ± 13.73	44.96 ± 17.53	0.050	0.020
EF, %	59.78 ± 11.69	63.97 ± 8.51	50.97 ± 11.88	0.207	0.076
GLS, %	-18.92 ± 4.98	-21.45 ± 3.73	-13.43 ± 4.30	0.083	0.004
GCS, %	-29.27 ± 9.06	-31.17 ± 6.93	-23.99 ± 7.30	0.481	0.095
SDI, %	5.83 ± 1.17	4.59 ± 1.56	8.66 ± 5.12	0.033	0.098
SDII, %	11.70 ± 2.36	8.72 ± 5.85	12.27 ± 4.78	0.180	0.761
Twist, °	12.67 ± 3.11	13.88 ± 8.39	14.25 ± 8.78	0.704	0.643
Torsion, °/cm	1.55 ± 0.44	1.89 ± 1.14	1.85 ± 1.12	0.433	0.491

P1: P values between the PRKAG2 group and the healthy volunteers; P2: P values between the PRKAG2 group and the sarcomeric HCM group. EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EF ejection fraction, GLS global longitudinal strain, GCS global circumferential strain, SDI systolic timing deviation index, SDII systolic timing dispersion index

ISSN: 1476-7120